BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6435641)

  • 1. Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitation.
    Balestrieri G; Tincani A; Migliorini P; Ferri C; Cattaneo R; Bombardieri S
    Arthritis Rheum; 1984 Oct; 27(10):1130-6. PubMed ID: 6435641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM-RF prevents complement-mediated inhibition of immune precipitation.
    Mitchell WS; Naama JK; Veitch J; Whaley K
    Immunology; 1984 Jul; 52(3):445-8. PubMed ID: 6745994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
    O'Sullivan MM; Amos N; Williams BD
    Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
    Naama JK; Mitchell WS; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
    Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
    Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal process in primary Sjögren's syndrome and cross-reactive idiotype associated with rheumatoid factor.
    Katsikis PD; Youinou PY; Galanopoulou V; Papadopoulos NM; Tzioufas AG; Moutsopoulos HM
    Clin Exp Immunol; 1990 Dec; 82(3):509-14. PubMed ID: 2124958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional affinity of IgM rheumatoid factor in patients with rheumatoid arthritis and other autoimmune diseases.
    Rath S; Hogben DN; Devey ME
    Ann Rheum Dis; 1988 Apr; 47(4):291-4. PubMed ID: 3365027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
    Doekes G; Schouten J; Cats A; Daha MR
    Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic study of rheumatoid factor influence on complement-mediated modulation of immune precipitation.
    Miletić VD; Rodić BD
    Complement; 1985; 2(4):204-10. PubMed ID: 3830556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of complement-mediated solubilisation of antigen-antibody complexes by serum factor(s) in patients with various connective tissue diseases.
    Webb J; Zoma A; Cobb S; Veitch J; Whaley K
    Aust N Z J Med; 1986 Aug; 16(4):445-51. PubMed ID: 3492194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement fixation by a two-component antibody system: immunoglobulin G and immunoglobulin M anti-globulin (rheumatoid factor). Parodoxical effect related to immunoglobulin G concentration.
    Schmid FR; Roitt IM; Rocha MJ
    J Exp Med; 1970 Oct; 132(4):673-93. PubMed ID: 5508376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies.
    Anquetil F; Clavel C; Offer G; Serre G; Sebbag M
    J Immunol; 2015 Apr; 194(8):3664-74. PubMed ID: 25769920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA rheumatoid factor in the sera and saliva of patients with rheumatoid arthritis and Sjögren's syndrome.
    Dunne JV; Carson DA; Spiegelberg HL; Alspaugh MA; Vaughan JH
    Ann Rheum Dis; 1979 Apr; 38(2):161-5. PubMed ID: 443882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of the rheumatoid factor on fixation of immune complex-complement complex on erythrocytes].
    Hirose S; Yukiyama Y; Saito K; Ishii N
    Ryumachi; 1983 Jun; 23(3):135-40. PubMed ID: 6623211
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of hidden complement fixing IgM rheumatoid factor in adult seronegative rheumatoid arthritis.
    Robbins DL; Moore TL
    Ann Rheum Dis; 1980 Feb; 39(1):64-7. PubMed ID: 7377862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement fixation by rheumatoid factor.
    Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
    J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influences of rheumatoid factors on solubilization of precipitating immune complex due to complement].
    Hirose S; Saito K; Yukiyama Y; Ishii N
    Ryumachi; 1982 Aug; 22(4):308-14. PubMed ID: 7179026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.